iBio, Inc. to Present Plant-Made Pharmaceutical Platform at Plant-Based Vaccines, Antibodies & Biologics Conference
June 05, 2017 08:30 ET
|
iBio, Inc.
NEW YORK, June 05, 2017 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSE MKT:IBIO), a leader in developing plant-based biopharmaceuticals, announced today that Barry Holtz, PhD, President of iBio CMO LLC is...
iBio, Inc. Provides Corporate Update at Annual Shareholders Meeting
May 04, 2017 16:01 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - May 4, 2017) - iBio, Inc. (NYSE MKT: IBIO), a leader in developing plant-based biopharmaceuticals, announced today that it provided a corporate update at its Annual...
Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action
January 27, 2017 08:30 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Jan 27, 2017) - iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider...
Another iBio Plague Vaccine Patent Issues
November 21, 2016 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Nov 21, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue of...
iBio Expands Product Development Capacity of cGMP Plant
November 10, 2016 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Nov 10, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced completion...
iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd
September 29, 2016 08:30 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Sep 29, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products announced the...
Implications of Court Decision in Favor of iBio Against Fraunhofer
August 15, 2016 08:30 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Aug 15, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, commented further...
iBio, Inc.'s Claims Against Fraunhofer Affirmed by Delaware Chancery Court
August 04, 2016 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Aug 4, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced today that...
iBio, Inc. Receives FDA Orphan Drug Designation for Fibrosis Product Candidate
July 05, 2016 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Jul 5, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced that the...
iBio, Inc. Receives New Patent for Its Biotherapeutic Products for Treatment of Fibrosis
June 29, 2016 08:31 ET
|
iBio, Inc.
NEW YORK, NY--(Marketwired - Jun 29, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products, announced the issue...